Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$82,994,856
+$72,879,685 QoQ
Shares Held
326,790
+689.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#334
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. JNJ ranks #1 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,994,856 | 326,790 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $10,115,171 | 41,381 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,687,796 | 32,316 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,909,478 | 139,734 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,181,477 | 20,828 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,780,804 | 16,768 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,481,823 | 17,161 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,508,526 | 15,479 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,283,164 | 15,621 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,414,769 | 15,265 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,671,475 | 17,044 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,692,917 | 17,290 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,871,275 | 17,347 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,677,470 | 17,274 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $3,064,524 | 17,348 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $2,850,958 | 17,452 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,924,477 | 16,475 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $2,825,223 | 15,941 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,725,316 | 15,931 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,565,750 | 15,887 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,578,181 | 15,650 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $2,441,908 | 15,516 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,310,022 | 15,516 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,276,940 | 16,191 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,223,833 | 16,959 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||